Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Zhejiang Tianrui Pharmaceutical is a Chinese pharmaceutical company focused on the development, production, and sale of integrated traditional Chinese and Western medicines. Founded in 1998 and headquartered in Pan'an, Zhejiang, the company specializes in treatments for cardiovascular, cerebrovascular, and respiratory conditions. Its flagship products include Ginkgo biloba extract preparations, which are widely used in the Chinese market for circulatory health and cognitive support. The company operates multiple GMP-certified manufacturing lines for various dosage forms, including large and small volume injections, tablets, and capsules. Zhejiang Tianrui Pharmaceutical maintains a strong regional presence and contributes to the modernization of traditional herbal therapies through standardized extraction and purification processes.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Zhejiang Tianrui.